Paper26317628
Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages.
Mortaz E and 7 others. PLoS One, 2015. Cited by 85 papers, by iCite.
Cite this record
ConductScience Library. Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages. Papers, record 26317628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26317628
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-Inflammatory Effects of Lactobacillus Rahmnosus and Bifidobacterium Breve on Cigarette Smoke Activated Human Macrophages.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macrophage Activation | Major topic |
| Macrophages | Major topic |
| Probiotics | Major topic |
| Nicotiana | Major topic |
| Bifidobacterium | |
| Cell Line | |
| Cytokines | |
| Humans | |
| Lacticaseibacillus rhamnosus | |
| Phagocytosis | |
| Smoke | |
| Toll-Like Receptors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| 093080/Z/10/Z | Wellcome Trust | United Kingdom | PubMed | |
| G1001367/1 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04876833 | Characteristics of Intestinal Microbiome in the Progression of Early COPD | Results |
Source ClinicalTrials.gov
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21430413 | Chronic obstructive pulmonary disease and lung cancer: new molecular insights. | Respiration | 2011 | https://conductscience.org/library/papers/21430413 | PubMed |
| 2 | 22895087 | Nonpathogenic Lactobacillus rhamnosus activates the inflammasome and antiviral responses in human macrophages. | Gut Microbes | 2012 | https://conductscience.org/library/papers/22895087 | PubMed |
| 3 | 21554343 | Lactobacillus pentosus strain b240 suppresses pneumonia induced by Streptococcus pneumoniae in mice. | Lett Appl Microbiol | 2011 | https://conductscience.org/library/papers/21554343 | PubMed |
| 4 | 12052801 | Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. | BMJ | 2002 | https://conductscience.org/library/papers/12052801 | PubMed |
| 5 | 22427534 | Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. | Am J Respir Crit Care Med | 2012 | https://conductscience.org/library/papers/22427534 | PubMed |
| 6 | 20082474 | Pulmonary involvement and allergic disorders in inflammatory bowel disease. | World J Gastroenterol | 2010 | https://conductscience.org/library/papers/20082474 | PubMed |
| 7 | 25446104 | Secondhand smoke exposure-induced nucleocytoplasmic shuttling of HMGB1 in a rat premature skin aging model. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/25446104 | PubMed |
| 8 | 17630319 | Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. | Am J Respir Cell Mol Biol | 2007 | https://conductscience.org/library/papers/17630319 | PubMed |
| 9 | 23737654 | Probiotics in the management of lung diseases. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/23737654 | PubMed |
| 10 | 24493496 | Lung-gut cross talk: a potential mechanism for intestinal dysfunction in patients with COPD. | Chest | 2014 | https://conductscience.org/library/papers/24493496 | PubMed |
| 11 | 24430176 | Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. | Thorax | 2014 | https://conductscience.org/library/papers/24430176 | PubMed |
| 12 | 12408432 | Probiotics: clinics and/or nutrition. | Dig Liver Dis | 2002 | https://conductscience.org/library/papers/12408432 | PubMed |
| 13 | 19494220 | Immunologic aspects of chronic obstructive pulmonary disease. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19494220 | PubMed |
| 14 | 25192219 | Cigarette smoke-induced damage-associated molecular pattern release from necrotic neutrophils triggers proinflammatory mediator release. | Am J Respir Cell Mol Biol | 2015 | https://conductscience.org/library/papers/25192219 | PubMed |
| 15 | 21457800 | Long-term exposure to cigarette smoke impairs lung function and increases HMGB-1 expression in mice. | Respir Physiol Neurobiol | 2011 | https://conductscience.org/library/papers/21457800 | PubMed |
| 16 | 16822173 | Recognition and signaling by toll-like receptors. | Annu Rev Cell Dev Biol | 2006 | https://conductscience.org/library/papers/16822173 | PubMed |
| 17 | 19840968 | Cigarette smoke induces CXCL8 production by human neutrophils via activation of TLR9 receptor. | Eur Respir J | 2010 | https://conductscience.org/library/papers/19840968 | PubMed |
| 18 | 21996276 | Lactobacillus gasseri suppresses Th17 pro-inflammatory response and attenuates allergen-induced airway inflammation in a mouse model of allergic asthma. | Br J Nutr | 2012 | https://conductscience.org/library/papers/21996276 | PubMed |
| 19 | 12848850 | Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. | Immunol Cell Biol | 2003 | https://conductscience.org/library/papers/12848850 | PubMed |
| 20 | 25268890 | Lactobacillus helveticus SBT2171 inhibits lymphocyte proliferation by regulation of the JNK signaling pathway. | PLoS One | 2014 | https://conductscience.org/library/papers/25268890 | PubMed |
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42564122 | Cigarette smoke modulates virulence-related properties and host immune responses in Klebsiella pneumoniae. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42564122 | PubMed |
| 42540465 | May nutrients and dietary supplements influence the gut-lung microbiota axis in chronic obstructive pulmonary disease and exacerbations? | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42540465 | PubMed |
| 42405211 | Respiratory Microbiome Remodeling in Aging: Implications for Immunosenescence and Therapeutic Intervention. | Immune Netw | 2026 | https://conductscience.org/library/papers/42405211 | PubMed |
| 42319604 | Oral administration of Lactiplantibacillus plantarum 6.2 mitigates acute lung injury via immunostaining of the TLR4/NF-κB pathway and reduction of IL-17 in lung tissue. | Int Microbiol | 2026 | https://conductscience.org/library/papers/42319604 | PubMed |
| 41928236 | Longitudinal dynamics and site-specific recovery of the human respiratory microbiome following smoking cessation. | Respir Res | 2026 | https://conductscience.org/library/papers/41928236 | PubMed |
| 41870857 | Lactic Acid Bacteria with Probiotic Potential Regulating Macrophages: Mechanisms, Regulatory Features, and Clinical Applications. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41870857 | PubMed |
| 41861166 | Circulating cytokines mediate the risk of COPD: A mediation analysis based on 473 gut microbiota and 91 circulating cytokines. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/41861166 | PubMed |
| 41676136 | The gut-lung axis in COPD: immunomodulatory roles of gut microbiota and novel therapeutic strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/41676136 | PubMed |
| 41559166 | Host m6A modifications shape microbiota that drives cell specific ferroptosis as a causal pathway to chronic respiratory diseases. | Sci Rep | 2026 | https://conductscience.org/library/papers/41559166 | PubMed |
| 41324864 | Decoding the gut microbiota-mitochondrial-inflammasome axis in cardiovascular disease. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41324864 | PubMed |
| 40808958 | Chronic obstructive pulmonary disease: in-depth analysis of microbiota association and innovative prevention and treatment approaches from the gut-lung axis perspective. | Front Immunol | 2025 | https://conductscience.org/library/papers/40808958 | PubMed |
| 40702070 | LPS promotes the production of ROS in neutrophils to regulate their killing activity against Mycobacterium tuberculosis. | Sci Rep | 2025 | https://conductscience.org/library/papers/40702070 | PubMed |
| 39849413 | Association between dietary intake of live microbes and chronic obstructive pulmonary disease: a cross-sectional study of NHANES 2007-2012. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/39849413 | PubMed |
| 39738731 | Inhalation of patchouli essential oil alleviates airway inflammation in cigarette smoke-induced COPD mice. | Sci Rep | 2024 | https://conductscience.org/library/papers/39738731 | PubMed |
| 39446051 | The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease. | Gut Microbes | 2024 | https://conductscience.org/library/papers/39446051 | PubMed |
| 38794746 | RETRACTED: Involvement of GPR43 Receptor in Effect of Lacticaseibacillus rhamnosus on Murine Steroid Resistant Chronic Obstructive Pulmonary Disease: Relevance to Pro-Inflammatory Mediators and Oxidative Stress in Human Macrophages. | Nutrients | 2024 | https://conductscience.org/library/papers/38794746 | PubMed |
| 38771520 | Does "all disease begin in the gut"? The gut-organ cross talk in the microbiome. | Appl Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/38771520 | PubMed |
| 38635003 | Application of Microbiome-Based Therapies in Chronic Respiratory Diseases. | J Microbiol | 2024 | https://conductscience.org/library/papers/38635003 | PubMed |
| 38455077 | Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic applications. | Microbiome Res Rep | 2024 | https://conductscience.org/library/papers/38455077 | PubMed |
| 38228603 | Lung microbiome: new insights into the pathogenesis of respiratory diseases. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38228603 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26317628
GET https://conductscience.org/api/papers/v1/26317628/references?page=2